Maiwei Bio: application for 7MW3711 clinical trial for injection accepted

FAP, May 10 / PRNewswire-FirstCall-Asianet /-- Maiwei Biological announced that the application for clinical trial of 7MW3711 for injection was accepted. 7MW3711 is a new antibody-coupled drug targeting B7-H3 for advanced solid tumors.